Upkara seeks partnerships for breakthrough biomolecule stabilization technology under leadership of new CEO

Samba Scientific

ANN ARBOR, Mich., May 8, 2024 /PRNewswire/

Upkara, a biotechnology company specializing in stabilization of biomolecules, today announced the launch of a proprietary technology that eliminates the need for cold storage or lyophilization (freeze-drying) for preserving biological molecules, dramatically simplifying the manufacturing, shipping, and use of analytical products such as research assays and diagnostic test kits.

The novel stabilization technology, called capillary-mediated vitrification (CMV), quickly evaporates water from samples without the freezing step that makes lyophilization expensive, time consuming, and results in reduced product yields. The more rapid Upkara process preserves proteins, antibodies, nucleic acids, enzymes, and other biologicals, stabilizing them for months to years at ambient or above-ambient temperatures. The technology streamlines product development and manufacturing, reduces supply chain risks, curtails expenses, expands market access, and improves sustainability.

Read the full article on prnewswire.com

Share this page on social

Ready to get started? See what Samba can do for you.